SpliSense
- Biotech or pharma, therapeutic R&D
SpliSense is a clinical-stage biotechnology company developing transformative RNA-based therapies using antisense oligonucleotides (ASOs) for pulmonary diseases. Its clinically validated platform targets conditions such as COPD, asthma, NCFB, IPF, and unmet cystic fibrosis (CF) mutations
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}